Research view
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.
EU-13 is a filter, not a ranking: it only narrows the list.
Shanghai Jiao Tong University · Shanghai, China
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Nat Biomed Eng, Dec 2025A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity.
Sun Yat-sen University · Guangzhou, China
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Nat Commun, Jan 2026Neoadjuvant chemoradiotherapy plus sintilimab in proficient mismatch repair locally advanced rectal cancer with intermediate/high-immunoscore (SILAR): a single-arm phase II trial.
Shanghai, China
Beijing, China
Harvard University · Cambridge, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Cancer Epidemiol Biomarkers Prev, Mar 2026Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer.
Houston, United States
Hangzhou, China
Nanjing, China
Southern Medical University · Guangzhou, China
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · J Immunother Cancer, Jan 2026Memory B cell subset shapes antitumor immunity and response to PD-1 blockade in mismatch repair-deficient colorectal cancers.
Chinese Academy of Sciences · Beijing, China
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · ACS Appl Mater Interfaces, Nov 2025Selenium-Enriched Cerium Oxidative Nanoplatform for Colorectal Tumor Surgery with the Guidance of NIR II Fluorescent Bioimaging and Tumor-Microenvironment Triggered Synergistic Therapy.
Rochester, United States
Nanjing, China
Huazhong University of Science and Technology · Wuhan, China
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Adv Sci (Weinh), Jan 2026Targeting Peptostreptococcus anaerobius with an Iron-Based Nanozyme Reverses Ferroptosis Resistance and Enhances Antitumor Immunity in Colorectal Cancer.
Heidelberg, Germany
Paris, France
Chengdu, China
New York, United States
Duarte, United States
Guangzhou, China
Capital Medical University · Beijing, China
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Cell Commun Signal, Jan 2026Hyperglycemia drives lmmune evasion in colorectal cancer through VISTA stabilization.
Guangzhou, China
Shanghai, China
Chengdu, China
Massachusetts General Hospital · Boston, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Cancer Immunol Res, Jan 2026T-cell Subset Features and Distributions Evolve across the Colorectal Precancer-Cancer Spectrum.
24 of 4,665 institutions, ordered by recent publications and open trials. This is not a ranking of quality.
Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.
Terminated
Cryptosporidium Infection and Human Colorectal Cancer
“No other patients could be included within the time frame.”Registry text, quoted unchanged. SourceTerminated
CT-95 in Advanced Cancers Associated With Mesothelin Expression
“The study was halted prematurely and will not resume; participants are no longer receiving intervention or undergoing evaluations. The termination was not due to any safety or efficacy concerns.”Registry text, quoted unchanged. SourceWithdrawn
ctDNA and Organ Preservation/Pathologic CR in Rectal Cancer
“Funding issues”Registry text, quoted unchanged. SourceTerminated
KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer
“The study was stopped early due to lack of efficacy.”Registry text, quoted unchanged. SourceSuspended
“PI Request”Registry text, quoted unchanged. SourceSuspended
A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma
“Protocol is with FDA review, waiting for funding to be released”Registry text, quoted unchanged. SourceTerminated
“The Sponsor terminated the trial early for strategic business reasons. This isn't related to any safety/efficacy/clinical activity/benefit-risk concern with petosemtamab. Ongoing participants will have access to treatment outside of this trial.”Registry text, quoted unchanged. SourceTerminated
A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors
“Company's strategic decision”Registry text, quoted unchanged. SourceTerminated
The Impact of Laparotomy and Analgesia Methods on Diaphragm
“The study was terminated prematurely because the planned sample size could not be achieved due to insufficient participant recruitment.”Registry text, quoted unchanged. SourceSuspended
EXtended CriteriA Treatment for LIver Metastases and Heavy Tumour BURden
“Not enough patients”Registry text, quoted unchanged. SourceTrials whose registry record says individual participant data (IPD) will be shared.
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed. Machine-matched links are labelled.